{"id":9335,"date":"2026-09-29T09:23:43","date_gmt":"2026-09-29T09:23:43","guid":{"rendered":"https:\/\/aptechka.store\/?post_type=product&#038;p=9335"},"modified":"2026-09-29T13:24:23","modified_gmt":"2026-09-29T13:24:23","slug":"buy-mexidol-125mg-usa","status":"publish","type":"product","link":"https:\/\/aptechka.store\/es\/shop\/buy-mexidol-125mg-usa\/","title":{"rendered":"Mexidol 125 mg 30 tablets | Anti Anxiety Relief | Reduces tension &amp; Emotional burnout | Enhances memory | Protects brain cells from oxygen deficiency (hypoxia)"},"content":{"rendered":"\t\t<div data-elementor-type=\"product-post\" data-elementor-id=\"9335\" class=\"elementor elementor-9335\" data-elementor-post-type=\"product\">\n\t\t\t\t<div class=\"elementor-element elementor-element-36ae8a51 e-flex e-con-boxed e-con e-parent\" data-id=\"36ae8a51\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-5c29d5b e-con-full e-flex e-con e-child\" data-id=\"5c29d5b\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-a4fe7dc elementor-widget elementor-widget-heading\" data-id=\"a4fe7dc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\"><a href=\"https:\/\/aptechka.store\/healthcare-disclaimer\/\">FDA DISCLAIMER: These statements have not been evaluated by the Food and Drug Administration (FDA). If you are searching to buy mexidol 125mg USA, please note that Aptechka.store provides 100% original Mexidol 125 mg 30 tablets | Anti Anxiety Relief | Reduces tension &amp; Emotional burnout | Enhances memory | Protects brain cells from oxygen deficiency (hypoxia) for personal use. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult your attending physician strictly before starting any new protocol.<\/a><\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-39aa2e74 elementor-widget elementor-widget-text-editor\" data-id=\"39aa2e74\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul class=\"wp-block-list\" style=\"line-height: 1.6;\"><li><strong>Product name:<\/strong> <a href=\"https:\/\/mexidol.ru\/\" target=\"_blank\" rel=\"noopener\">Mexidol 125 mg, 30 tablets<\/a><\/li><li><strong>Expiry:<\/strong> Jul 2031\u00a0<\/li><li><strong>Active ingredient:<\/strong> <a href=\"https:\/\/en.wikipedia.org\/wiki\/Emoxypine\" target=\"_blank\" rel=\"noopener\">Emoxypine succinate (ethylmethylhydroxypyridine succinate)<\/a>, 125 mg per tablet<\/li><li><strong>Dosage form:<\/strong> Film-coated tablets, 30 count<\/li><li><strong>Manufacturer:<\/strong> Pharmasoft<\/li><li><strong>Country of manufacture:<\/strong> Russia<\/li><li><strong>Availability:<\/strong> In Stock at US warehouse<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-753b27b e-flex e-con-boxed e-con e-parent\" data-id=\"753b27b\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-6b6104f elementor-widget elementor-widget-n-accordion\" data-id=\"6b6104f\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;default_state&quot;:&quot;all_collapsed&quot;,&quot;max_items_expended&quot;:&quot;one&quot;,&quot;n_accordion_animation_duration&quot;:{&quot;unit&quot;:&quot;ms&quot;,&quot;size&quot;:400,&quot;sizes&quot;:[]}}\" data-widget_type=\"nested-accordion.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"e-n-accordion\" aria-label=\"Accordion. Open links with Enter or Space, close with Escape, and navigate with Arrow Keys\">\n\t\t\t\t\t\t<details id=\"e-n-accordion-item-1120\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"1\" tabindex=\"0\" aria-expanded=\"false\" aria-controls=\"e-n-accordion-item-1120\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> Directions: <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t<span class='e-closed'><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-1120\" class=\"elementor-element elementor-element-9db0b54 e-con-full e-flex e-con e-child\" data-id=\"9db0b54\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-1120\" class=\"elementor-element elementor-element-7a9a982 e-flex e-con-boxed e-con e-child\" data-id=\"7a9a982\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-35e974d elementor-widget elementor-widget-text-editor\" data-id=\"35e974d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"mexidol-directions\"><p>Always use the medicine exactly as recommended by your treating physician. If you are unsure, consult your physician. The initial dose is 1\u20132 tablets (125\u2013250 mg) 1\u20132 times daily, gradually increasing until a therapeutic effect is achieved. The stated adult oral dose is 1\u20132 tablets (125\u2013250 mg) 3 times daily; the maximum daily dose is 6 tablets (750 mg).<\/p><p>For treatment of the consequences of acute cerebrovascular disorders, including after transient ischemic attacks, the tablets are prescribed after a course of the medicine as an intravenous or intramuscular solution. For children with attention-deficit\/hyperactivity disorder, including hyperactivity, impaired attention, and impulsivity, the leaflet states 1 tablet (125 mg) twice daily. Your treating physician may change the dose.<\/p><p>For oral use, swallow the tablet whole with water; do not break it. Treatment duration is 2\u20138 weeks. For children treated for attention-deficit\/hyperactivity disorder, the leaflet states 6 weeks. For people with ischemic heart disease, it states at least 6\u20138 weeks. Repeat courses, on a physician\u2019s recommendation, are preferably in spring and autumn. For alcohol-withdrawal syndrome, the stated duration is 5\u20137 days; treatment is stopped gradually by reducing the dose over 2\u20133 days. Do not use this translation to select a dose or treatment course.<\/p><p>The phrase <em>buy mexidol 125mg usa<\/em> is a search term, not a dosing instruction. The specific regimen must be determined by a qualified healthcare professional.<\/p><h3>Indications stated in the supplied leaflet<\/h3><p>The Russian-language leaflet states use for: consequences of acute cerebrovascular disorders, including after transient ischemic attacks, in the initial\/subcompensation stage as preventive courses; mild traumatic brain injury and its consequences; encephalopathies of various origins (circulatory, metabolic, post-traumatic, or mixed); autonomic dystonia syndrome; mild cognitive impairment of atherosclerotic origin; anxiety disorders in neurotic and neurotic-like conditions; ischemic heart disease as part of combination therapy; alcohol-withdrawal syndrome in chronic alcoholism with predominantly neurotic and autonomic-vascular disorders and delayed post-withdrawal disorders; conditions after acute intoxication with antipsychotic medicines; asthenic conditions and prevention of somatic diseases under extreme factors and stress; and attention-deficit\/hyperactivity disorder in children, including hyperactivity, impaired attention, and impulsivity.<\/p><p>These are statements from the supplied foreign-language leaflet and are not U.S. indications. If you searched for <em>buy mexidol 125mg usa<\/em>, consult a licensed healthcare professional about applicable local requirements before considering any use.<\/p><h3>Composition<\/h3><p>Each tablet contains 125.0 mg of ethylmethylhydroxypyridine succinate. Excipients: lactose monohydrate, povidone K-30, and magnesium stearate. Film coating: hypromellose, titanium dioxide, lactose monohydrate, macrogol, and triacetin. The leaflet states that the product contains lactose.<\/p><h3>Contraindications<\/h3><p>Do not use, according to the supplied leaflet, if you are allergic to ethylmethylhydroxypyridine succinate or any other ingredient; have acute liver or kidney dysfunction; are under 6 years of age; are pregnant or breastfeeding; or have intolerance to certain sugars (the product contains lactose). The source leaflet says use is contraindicated during pregnancy and breastfeeding.<\/p><h3>Warnings and precautions<\/h3><p>Consult your treating physician before use. Tell your physician if you have intolerance to certain sugars because the product contains lactose. Use in children younger than 6 years is not recommended in the supplied leaflet because of insufficient efficacy and safety data. If you are pregnant, breastfeeding, think you may be pregnant, or plan to become pregnant, consult a healthcare professional; the leaflet states the medicine is contraindicated during pregnancy and breastfeeding. Use caution when driving or operating machinery or performing tasks requiring quick psychomotor reactions.<\/p><p>A search for <em>buy mexidol 125mg usa<\/em> cannot replace a clinician\u2019s assessment of contraindications, interactions, or local regulatory status.<\/p><h3>Pack and dosage form<\/h3><p>Film-coated tablets, 125 mg; 30 tablets per package, supplied with instructions for use.<\/p><h3>Possible adverse reactions<\/h3><p>As with other medicines, the supplied leaflet reports possible adverse reactions, although they do not occur in everyone. Very rare reported reactions (up to 1 in 10,000 people) include a serious allergic reaction such as difficulty breathing or swelling of the face, neck, lips, tongue, or throat (angioedema); itchy allergic rash (urticaria); drowsiness; headache; dry mouth; nausea; stomach\/epigastric pain, burning, or discomfort; heartburn; flatulence; diarrhea; rash; itching; and skin redness. Seek medical attention for a severe or unusual reaction.<\/p><h3>Pharmacotherapeutic group<\/h3><p>Antioxidant agent, as stated in the supplied leaflet.<\/p><h3>Interactions<\/h3><p>Tell your treating physician about medicines you take, have recently taken, or may take. The supplied leaflet says the medicine may be used with medicines for somatic diseases and may enhance the effects of sedatives or sleeping medicines (for example, diazepam or midazolam), antidepressants, medicines for anxiety (including phenibut), antiepileptic medicines (including valproate or lamotrigine), and antiparkinsonian medicines. It also states that the medicine reduces the toxic effects of ethyl alcohol. Do not infer that a combination is appropriate for you; obtain professional advice.<\/p><h3>Pharmacodynamics stated in the supplied leaflet<\/h3><p>The leaflet identifies ethylmethylhydroxypyridine succinate as the active ingredient and classifies it as an antioxidant. It describes proposed activity related to oxidative processes in nervous and cardiovascular diseases and alcohol or medicine intoxication, and states that the medicine may increase resistance to damaging factors associated with shock, tissue hypoxia, ischemia, cerebrovascular disorders, and certain intoxications. These statements are translated from the supplied leaflet and are not independent evidence of clinical benefit in the United States.<\/p><h3>Storage<\/h3><p>Store at 2\u201325 \u00b0C, according to the supplied leaflet.<\/p><h3>Appearance<\/h3><p>Round, biconvex, film-coated tablets, white to white with a yellowish tint; the supplied leaflet notes a characteristic odor may be present.<\/p><h3>Pharmacokinetics stated in the supplied leaflet<\/h3><p>The leaflet states that the medicine is rapidly absorbed after oral use; the maximum concentration after doses of 400\u2013500 mg is 3.5\u20134.0 \u03bcg\/mL; it distributes rapidly in organs and tissues; average retention after oral use is 4.9\u20135.2 hours; it is metabolized in the liver by glucuronidation; and it is mainly excreted in urine as metabolites, with a smaller amount unchanged. The leaflet reports an oral half-life of 2.0\u20132.6 hours and says excretion is most intensive during the first 4 hours. These translated statements are not a U.S. prescribing recommendation.<\/p><h3>Overdose and missed dose<\/h3><p>The supplied leaflet says overdose may cause drowsiness or insomnia and that symptoms generally resolve on their own within 24 hours; seek medical care for pronounced symptoms. If a dose is missed, do not take a double dose to make up for it; take the next dose at the usual time. If you have questions about use, contact a healthcare professional.<\/p><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t<details id=\"e-n-accordion-item-1121\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"2\" tabindex=\"-1\" aria-expanded=\"false\" aria-controls=\"e-n-accordion-item-1121\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> References: <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t<span class='e-closed'><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-1121\" class=\"elementor-element elementor-element-da6f0c5 e-flex e-con-boxed e-con e-child\" data-id=\"da6f0c5\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-1121\" class=\"elementor-element elementor-element-3c066c1 e-con-full e-flex e-con e-child\" data-id=\"3c066c1\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-66d3133 elementor-widget elementor-widget-text-editor\" data-id=\"66d3133\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ol><li>Gruber W (1953).\u00a0<a id=\"mwqg\" class=\"external text\" href=\"https:\/\/doi.org\/10.1139%2Fv53-079\" rel=\"mw:ExtLink nofollow noopener\" target=\"_blank\">\u00abSynthesis of 3-Hydroxy-2-alkylpyridines\u00bb<\/a>.\u00a0<i id=\"mwqw\">Canadian Journal of Chemistry<\/i>.\u00a0<b id=\"mwrA\">31<\/b>\u00a0(6):\u00a0<span id=\"mwrQ\" class=\"nowrap\">564\u2013<\/span>568.\u00a0<a id=\"mwrg\" class=\"mw-redirect\" title=\"Doi (identifier)\" href=\"https:\/\/en.wikipedia.org\/wiki\/Doi_(identifier)\" rel=\"mw:WikiLink noopener\" target=\"_blank\">doi<\/a>:<span id=\"mwrw\" class=\"id-lock-free\" title=\"Freely accessible\"><a id=\"mwsA\" class=\"external text\" href=\"https:\/\/doi.org\/10.1139%2Fv53-079\" rel=\"mw:ExtLink nofollow noopener\" target=\"_blank\">10.1139\/v53-079<\/a><\/span>.<\/li><li id=\"cite_note-mexidol-2011-2\" data-mw-footnote-number=\"2\">\u00a0<span id=\"mw-reference-text-cite_note-mexidol-2011-2\" class=\"mw-reference-text reference-text\"><cite id=\"mwtg\" class=\"citation web cs1\"><a id=\"mwtw\" class=\"external text\" href=\"https:\/\/web.archive.org\/web\/20110410103710\/http:\/\/www.mexidol.ru\/en\/\" rel=\"mw:ExtLink nofollow noopener\" target=\"_blank\">\u00abmexidol.ru, Pharmasoft Website\u00bb<\/a>. Archived from\u00a0<a id=\"mwuA\" class=\"external text\" href=\"http:\/\/www.mexidol.ru\/en\" rel=\"mw:ExtLink nofollow noopener\" target=\"_blank\">the original<\/a>\u00a0on 2011-04-10<span id=\"mwuQ\" class=\"reference-accessdate\">. Retrieved\u00a0<span id=\"mwug\" class=\"nowrap\">2011-04-27<\/span><\/span>.<\/cite><\/span><\/li><li id=\"cite_note-pmid17117675-4\" data-mw-footnote-number=\"4\"><span id=\"mw-reference-text-cite_note-pmid17117675-4\" class=\"mw-reference-text reference-text\"><cite id=\"CITEREFLikhachevaSholomov2006\" class=\"citation journal cs1\">Likhacheva EB, Sholomov II (2006). \u00ab[Clinical and immunological assessment of efficacy of mexidol in the treatment of lumbosacral radiculopathy]\u00bb.\u00a0<i id=\"mw1A\">Zhurnal Nevrologii I Psikhiatrii imeni S.S. Korsakova<\/i>.\u00a0<b id=\"mw1Q\">106<\/b>\u00a0(10):\u00a0<span id=\"mw1g\" class=\"nowrap\">52\u2013<\/span>7.\u00a0<a id=\"mw1w\" class=\"mw-redirect\" title=\"PMID (identifier)\" href=\"https:\/\/en.wikipedia.org\/wiki\/PMID_(identifier)\" rel=\"mw:WikiLink noopener\" target=\"_blank\">PMID<\/a><span id=\"mw2A\">\u00a0<\/span><a id=\"mw2Q\" class=\"external text\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17117675\" rel=\"mw:ExtLink nofollow noopener\" target=\"_blank\">17117675<\/a>.<\/cite><span id=\"mw2g\" class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Zhurnal+Nevrologii+I+Psikhiatrii+imeni+S.S.+Korsakova&amp;rft.atitle=%5BClinical+and+immunological+assessment+of+efficacy+of+mexidol+in+the+treatment+of+lumbosacral+radiculopathy%5D&amp;rft.volume=106&amp;rft.issue=10&amp;rft.pages=52-7&amp;rft.date=2006&amp;rft_id=info%3Apmid%2F17117675&amp;rft.aulast=Likhacheva&amp;rft.aufirst=EB&amp;rft.au=Sholomov%2C+II&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEmoxypine\"><\/span><\/span><\/li><li id=\"cite_note-pmid25894772-5\" data-mw-footnote-number=\"5\"><span id=\"mw2w\" class=\"mw-cite-backlink\"><a id=\"mw3A\" title=\"Jump up\" href=\"https:\/\/en.wikipedia.org\/wiki\/Emoxypine#cite_ref-pmid25894772_5-0\" rel=\"mw:referencedBy noopener\" aria-label=\"Jump up\" target=\"_blank\"><\/a><\/span>\u00a0<span id=\"mw-reference-text-cite_note-pmid25894772-5\" class=\"mw-reference-text reference-text\"><cite id=\"CITEREFVolchegorskiiMiroshnichenkoRassokhinaFaizullin2015\" class=\"citation journal cs1\">Volchegorskii IA, Miroshnichenko IY, Rassokhina LM, Faizullin RM, Malkin MP, Pryakhina KE, et<span id=\"mw3w\">\u00a0<\/span>al. (April 2015). \u00abComparative analysis of the anxiolytic effects of 3-hydroxypyridine and succinic acid derivatives\u00bb.\u00a0<i id=\"mw4A\">Bulletin of Experimental Biology and Medicine<\/i>.\u00a0<b id=\"mw4Q\">158<\/b>\u00a0(6):\u00a0<span id=\"mw4g\" class=\"nowrap\">756\u2013<\/span>61.\u00a0<a id=\"mw4w\" class=\"mw-redirect\" title=\"Doi (identifier)\" href=\"https:\/\/en.wikipedia.org\/wiki\/Doi_(identifier)\" rel=\"mw:WikiLink noopener\" target=\"_blank\">doi<\/a>:<a id=\"mw5A\" class=\"external text\" href=\"https:\/\/doi.org\/10.1007%2Fs10517-015-2855-3\" rel=\"mw:ExtLink nofollow noopener\" target=\"_blank\">10.1007\/s10517-015-2855-3<\/a>.\u00a0<a id=\"mw5Q\" class=\"mw-redirect\" title=\"PMID (identifier)\" href=\"https:\/\/en.wikipedia.org\/wiki\/PMID_(identifier)\" rel=\"mw:WikiLink noopener\" target=\"_blank\">PMID<\/a><span id=\"mw5g\">\u00a0<\/span><a id=\"mw5w\" class=\"external text\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25894772\" rel=\"mw:ExtLink nofollow noopener\" target=\"_blank\">25894772<\/a>.\u00a0<a id=\"mw6A\" class=\"mw-redirect\" title=\"S2CID (identifier)\" href=\"https:\/\/en.wikipedia.org\/wiki\/S2CID_(identifier)\" rel=\"mw:WikiLink noopener\" target=\"_blank\">S2CID<\/a><span id=\"mw6Q\">\u00a0<\/span><a id=\"mw6g\" class=\"external text\" href=\"https:\/\/api.semanticscholar.org\/CorpusID:6052275\" rel=\"mw:ExtLink nofollow noopener\" target=\"_blank\">6052275<\/a>.<\/cite><span id=\"mw6w\" class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bulletin+of+Experimental+Biology+and+Medicine&amp;rft.atitle=Comparative+analysis+of+the+anxiolytic+effects+of+3-hydroxypyridine+and+succinic+acid+derivatives&amp;rft.volume=158&amp;rft.issue=6&amp;rft.pages=756-61&amp;rft.date=2015-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A6052275%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25894772&amp;rft_id=info%3Adoi%2F10.1007%2Fs10517-015-2855-3&amp;rft.aulast=Volchegorskii&amp;rft.aufirst=IA&amp;rft.au=Miroshnichenko%2C+IY&amp;rft.au=Rassokhina%2C+LM&amp;rft.au=Faizullin%2C+RM&amp;rft.au=Malkin%2C+MP&amp;rft.au=Pryakhina%2C+KE&amp;rft.au=Kalugina%2C+AV&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEmoxypine\"><\/span><\/span><\/li><li id=\"cite_note-Rumyantseva-2012-6\" data-mw-footnote-number=\"6\"><span id=\"mw7A\" class=\"mw-cite-backlink\"><a id=\"mw7Q\" title=\"Jump up\" href=\"https:\/\/en.wikipedia.org\/wiki\/Emoxypine#cite_ref-Rumyantseva-2012_6-0\" rel=\"mw:referencedBy noopener\" aria-label=\"Jump up\" target=\"_blank\"><\/a><\/span>\u00a0<span id=\"mw-reference-text-cite_note-Rumyantseva-2012-6\" class=\"mw-reference-text reference-text\"><cite id=\"CITEREFRumyantsevaFedinSokhova2012\" class=\"citation journal cs1\">Rumyantseva SA, Fedin AI, Sokhova ON (October 2012). \u00abAntioxidant Treatment of Ischemic Brain Lesions\u00bb.\u00a0<i id=\"mw8A\">Neuroscience and Behavioral Physiology<\/i>.\u00a0<b id=\"mw8Q\">42<\/b>\u00a0(8):\u00a0<span id=\"mw8g\" class=\"nowrap\">842\u2013<\/span>845.\u00a0<a id=\"mw8w\" class=\"mw-redirect\" title=\"Doi (identifier)\" href=\"https:\/\/en.wikipedia.org\/wiki\/Doi_(identifier)\" rel=\"mw:WikiLink noopener\" target=\"_blank\">doi<\/a>:<a id=\"mw9A\" class=\"external text\" href=\"https:\/\/doi.org\/10.1007%2Fs11055-012-9646-3\" rel=\"mw:ExtLink nofollow noopener\" target=\"_blank\">10.1007\/s11055-012-9646-3<\/a>.\u00a0<a id=\"mw9Q\" class=\"mw-redirect\" title=\"S2CID (identifier)\" href=\"https:\/\/en.wikipedia.org\/wiki\/S2CID_(identifier)\" rel=\"mw:WikiLink noopener\" target=\"_blank\">S2CID<\/a><span id=\"mw9g\">\u00a0<\/span><a id=\"mw9w\" class=\"external text\" href=\"https:\/\/api.semanticscholar.org\/CorpusID:39971165\" rel=\"mw:ExtLink nofollow noopener\" target=\"_blank\">39971165<\/a>.<\/cite><span id=\"mw-A\" class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuroscience+and+Behavioral+Physiology&amp;rft.atitle=Antioxidant+Treatment+of+Ischemic+Brain+Lesions&amp;rft.volume=42&amp;rft.issue=8&amp;rft.pages=842-845&amp;rft.date=2012-10&amp;rft_id=info%3Adoi%2F10.1007%2Fs11055-012-9646-3&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A39971165%23id-name%3DS2CID&amp;rft.aulast=Rumyantseva&amp;rft.aufirst=SA&amp;rft.au=Fedin%2C+AI&amp;rft.au=Sokhova%2C+ON&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEmoxypine\"><\/span><\/span><\/li><li id=\"cite_note-Voronina-7\" data-mw-footnote-number=\"7\"><span id=\"mw-Q\" class=\"mw-cite-backlink\"><a id=\"mw-g\" href=\"https:\/\/en.wikipedia.org\/wiki\/Emoxypine#cite_ref-Voronina_7-0\" target=\"_blank\" rel=\"noopener\"><\/a><a id=\"mw_A\" href=\"https:\/\/en.wikipedia.org\/wiki\/Emoxypine#cite_ref-Voronina_7-1\" target=\"_blank\" rel=\"noopener\"><\/a><a id=\"mw_g\" href=\"https:\/\/en.wikipedia.org\/wiki\/Emoxypine#cite_ref-Voronina_7-2\" target=\"_blank\" rel=\"noopener\"><\/a><a id=\"mwAQA\" href=\"https:\/\/en.wikipedia.org\/wiki\/Emoxypine#cite_ref-Voronina_7-3\" target=\"_blank\" rel=\"noopener\"><\/a><a id=\"mwAQI\" href=\"https:\/\/en.wikipedia.org\/wiki\/Emoxypine#cite_ref-Voronina_7-4\" target=\"_blank\" rel=\"noopener\"><\/a><\/span>\u00a0<span id=\"mw-reference-text-cite_note-Voronina-7\" class=\"mw-reference-text reference-text\"><cite id=\"CITEREFVoronina\" class=\"citation web cs1\">Voronina TA.\u00a0<a id=\"mwAQU\" class=\"external text\" href=\"https:\/\/web.archive.org\/web\/20131105055936\/http:\/\/www.mexidol.ru\/en\/pro\/library\/farmacology\/item102573\" rel=\"mw:ExtLink nofollow noopener\" target=\"_blank\">\u00abANTIOXIDANT MEXIDOL. The main neuropsychotropic effects and the mechanism of action\u00bb<\/a>.\u00a0<i id=\"mwAQY\">Institute of Pharmacology<\/i>. Moscow, Russia: Russian Academy of Medical Sciences. Archived from\u00a0<a id=\"mwAQc\" class=\"external text\" href=\"http:\/\/www.mexidol.ru\/en\/pro\/library\/farmacology\/item102573\" rel=\"mw:ExtLink nofollow noopener\" target=\"_blank\">the original<\/a>\u00a0on 2013-11-05.<\/cite><span id=\"mwAQg\" class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Institute+of+Pharmacology&amp;rft.atitle=ANTIOXIDANT+MEXIDOL.+The+main+neuropsychotropic+effects+and+the+mechanism+of+action&amp;rft.aulast=Voronina&amp;rft.aufirst=TA&amp;rft_id=http%3A%2F%2Fwww.mexidol.ru%2Fen%2Fpro%2Flibrary%2Ffarmacology%2Fitem102573&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEmoxypine\"><\/span><\/span><\/li><li id=\"cite_note-pmid35992374-8\" data-mw-footnote-number=\"8\"><span id=\"mwAQk\" class=\"mw-cite-backlink\"><a id=\"mwAQo\" href=\"https:\/\/en.wikipedia.org\/wiki\/Emoxypine#cite_ref-pmid35992374_8-0\" target=\"_blank\" rel=\"noopener\"><\/a><a id=\"mwAQw\" href=\"https:\/\/en.wikipedia.org\/wiki\/Emoxypine#cite_ref-pmid35992374_8-1\" target=\"_blank\" rel=\"noopener\"><\/a><\/span>\u00a0<span id=\"mw-reference-text-cite_note-pmid35992374-8\" class=\"mw-reference-text reference-text\"><cite id=\"CITEREFGuptaBagwe_ParabKaur2022\" class=\"citation journal cs1\">Gupta DS, Bagwe Parab S, Kaur G (1 January 2022).\u00a0<a id=\"mwAQ8\" class=\"external text\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9389226\" rel=\"mw:ExtLink nofollow noopener\" target=\"_blank\">\u00abPromising effects of emoxypine and its succinate derivative in the management of various diseases-with insights on recent patent applications\u00bb<\/a>.\u00a0<i id=\"mwARA\">Current Research in Pharmacology and Drug Discovery<\/i>.\u00a0<b id=\"mwARE\">3<\/b>\u00a0100121.\u00a0<a id=\"mwARI\" class=\"mw-redirect\" title=\"Doi (identifier)\" href=\"https:\/\/en.wikipedia.org\/wiki\/Doi_(identifier)\" rel=\"mw:WikiLink noopener\" target=\"_blank\">doi<\/a>:<a id=\"mwARM\" class=\"external text\" href=\"https:\/\/doi.org\/10.1016%2Fj.crphar.2022.100121\" rel=\"mw:ExtLink nofollow noopener\" target=\"_blank\">10.1016\/j.crphar.2022.100121<\/a>.\u00a0<a id=\"mwARQ\" class=\"mw-redirect\" title=\"PMC (identifier)\" href=\"https:\/\/en.wikipedia.org\/wiki\/PMC_(identifier)\" rel=\"mw:WikiLink noopener\" target=\"_blank\">PMC<\/a><span id=\"mwARU\">\u00a0<\/span><span id=\"mwARY\" class=\"id-lock-free\" title=\"Freely accessible\"><a id=\"mwARc\" class=\"external text\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9389226\" rel=\"mw:ExtLink nofollow noopener\" target=\"_blank\">9389226<\/a><\/span>.\u00a0<a id=\"mwARg\" class=\"mw-redirect\" title=\"PMID (identifier)\" href=\"https:\/\/en.wikipedia.org\/wiki\/PMID_(identifier)\" rel=\"mw:WikiLink noopener\" target=\"_blank\">PMID<\/a><span id=\"mwARk\">\u00a0<\/span><a id=\"mwARo\" class=\"external text\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35992374\" rel=\"mw:ExtLink nofollow noopener\" target=\"_blank\">35992374<\/a>.<\/cite><span id=\"mwARs\" class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Research+in+Pharmacology+and+Drug+Discovery&amp;rft.atitle=Promising+effects+of+emoxypine+and+its+succinate+derivative+in+the+management+of+various+diseases-with+insights+on+recent+patent+applications&amp;rft.volume=3&amp;rft.artnum=100121&amp;rft.date=2022-01-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9389226%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F35992374&amp;rft_id=info%3Adoi%2F10.1016%2Fj.crphar.2022.100121&amp;rft.aulast=Gupta&amp;rft.aufirst=DS&amp;rft.au=Bagwe+Parab%2C+S&amp;rft.au=Kaur%2C+G&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9389226&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEmoxypine\"><\/span><\/span><\/li><li id=\"cite_note-Dumayev-1995-9\" data-mw-footnote-number=\"9\"><span id=\"mwARw\" class=\"mw-cite-backlink\"><a id=\"mwAR0\" title=\"Jump up\" href=\"https:\/\/en.wikipedia.org\/wiki\/Emoxypine#cite_ref-Dumayev-1995_9-0\" rel=\"mw:referencedBy noopener\" aria-label=\"Jump up\" target=\"_blank\"><\/a><\/span>\u00a0<span id=\"mw-reference-text-cite_note-Dumayev-1995-9\" class=\"mw-reference-text reference-text\"><cite id=\"CITEREFDumayevVoroninaSmirnov1995\" class=\"citation report cs1\">Dumayev KM, Voronina TA, Smirnov LD (1995). Antioxidants in the prophylaxis and therapy of CNS pathologies (Report). Moscow.<\/cite><span id=\"mwASA\" class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=report&amp;rft.btitle=Antioxidants+in+the+prophylaxis+and+therapy+of+CNS+pathologies.&amp;rft.place=Moscow&amp;rft.date=1995&amp;rft.aulast=Dumayev&amp;rft.aufirst=KM&amp;rft.au=Voronina%2C+TA&amp;rft.au=Smirnov%2C+LD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEmoxypine\"><\/span><sup id=\"mwASI\" class=\"noprint Inline-Template \"><span id=\"mwASM\">[<\/span><i id=\"mwASQ\"><a id=\"mwASU\" title=\"Wikipedia:Citing sources\" href=\"https:\/\/en.wikipedia.org\/wiki\/Wikipedia:Citing_sources\" rel=\"mw:WikiLink noopener\" target=\"_blank\"><span id=\"mwASY\" title=\"This citation requires a reference to the specific page or range of pages in which the material appears. (April 2023)\">page<span id=\"mwASc\">\u00a0<\/span>needed<\/span><\/a><\/i><span id=\"mwASg\">]<\/span><\/sup><\/span><\/li><li id=\"cite_note-pmid11544797-10\" data-mw-footnote-number=\"10\"><span id=\"mwASk\" class=\"mw-cite-backlink\"><a id=\"mwASo\" title=\"Jump up\" href=\"https:\/\/en.wikipedia.org\/wiki\/Emoxypine#cite_ref-pmid11544797_10-0\" rel=\"mw:referencedBy noopener\" aria-label=\"Jump up\" target=\"_blank\"><\/a><\/span>\u00a0<span id=\"mw-reference-text-cite_note-pmid11544797-10\" class=\"mw-reference-text reference-text\"><cite id=\"CITEREFKucherianu2001\" class=\"citation journal cs1\">Kucherianu VG (January 2001). \u00ab[Mexidol potentiates antiparkinsonian effect of L-DOPA in MPTP-induced parkinsonism model]\u00bb.\u00a0<i id=\"mwAS0\">Eksperimental&#8217;naia i Klinicheskaia Farmakologiia<\/i>.\u00a0<b id=\"mwAS4\">64<\/b>\u00a0(1):\u00a0<span id=\"mwAS8\" class=\"nowrap\">22\u2013<\/span>5.\u00a0<a id=\"mwATA\" class=\"mw-redirect\" title=\"PMID (identifier)\" href=\"https:\/\/en.wikipedia.org\/wiki\/PMID_(identifier)\" rel=\"mw:WikiLink noopener\" target=\"_blank\">PMID<\/a><span id=\"mwATE\">\u00a0<\/span><a id=\"mwATI\" class=\"external text\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/11544797\" rel=\"mw:ExtLink nofollow noopener\" target=\"_blank\">11544797<\/a>.<\/cite><span id=\"mwATM\" class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Eksperimental%27naia+i+Klinicheskaia+Farmakologiia&amp;rft.atitle=%5BMexidol+potentiates+antiparkinsonian+effect+of+L-DOPA+in+MPTP-induced+parkinsonism+model%5D&amp;rft.volume=64&amp;rft.issue=1&amp;rft.pages=22-5&amp;rft.date=2001-01&amp;rft_id=info%3Apmid%2F11544797&amp;rft.aulast=Kucherianu&amp;rft.aufirst=VG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEmoxypine\"><\/span><\/span><\/li><li id=\"cite_note-https-11\" data-mw-footnote-number=\"11\"><span id=\"mwATQ\" class=\"mw-cite-backlink\"><a id=\"mwATU\" title=\"Jump up\" href=\"https:\/\/en.wikipedia.org\/wiki\/Emoxypine#cite_ref-https_11-0\" rel=\"mw:referencedBy noopener\" aria-label=\"Jump up\" target=\"_blank\"><\/a><\/span>\u00a0<span id=\"mw-reference-text-cite_note-https-11\" class=\"mw-reference-text reference-text\"><cite id=\"CITEREFDa_CostaPereiraSaadatRudnicki2021\" class=\"citation journal cs1\">Da Costa BR, Pereira TV, Saadat P, Rudnicki M, Iskander SM, Bodmer NS, et<span id=\"mwATg\">\u00a0<\/span>al. (2021).\u00a0<a id=\"mwATk\" class=\"external text\" href=\"https:\/\/www.bmj.com\/content\/375\/bmj.n2321\" rel=\"mw:ExtLink nofollow noopener\" target=\"_blank\">\u00abEffectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: Network meta-analysis\u00bb<\/a>.\u00a0<i id=\"mwATo\">BMJ (Clinical Research Ed.)<\/i>.\u00a0<b id=\"mwATs\">375<\/b>\u00a0n2321.\u00a0<a id=\"mwATw\" class=\"mw-redirect\" title=\"Doi (identifier)\" href=\"https:\/\/en.wikipedia.org\/wiki\/Doi_(identifier)\" rel=\"mw:WikiLink noopener\" target=\"_blank\">doi<\/a>:<a id=\"mwAT0\" class=\"external text\" href=\"https:\/\/doi.org\/10.1136%2Fbmj.n2321\" rel=\"mw:ExtLink nofollow noopener\" target=\"_blank\">10.1136\/bmj.n2321<\/a>.\u00a0<a id=\"mwAT4\" class=\"mw-redirect\" title=\"PMC (identifier)\" href=\"https:\/\/en.wikipedia.org\/wiki\/PMC_(identifier)\" rel=\"mw:WikiLink noopener\" target=\"_blank\">PMC<\/a><span id=\"mwAT8\">\u00a0<\/span><span id=\"mwAUA\" class=\"id-lock-free\" title=\"Freely accessible\"><a id=\"mwAUE\" class=\"external text\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8506236\" rel=\"mw:ExtLink nofollow noopener\" target=\"_blank\">8506236<\/a><\/span>.\u00a0<a id=\"mwAUI\" class=\"mw-redirect\" title=\"PMID (identifier)\" href=\"https:\/\/en.wikipedia.org\/wiki\/PMID_(identifier)\" rel=\"mw:WikiLink noopener\" target=\"_blank\">PMID<\/a><span id=\"mwAUM\">\u00a0<\/span><a id=\"mwAUQ\" class=\"external text\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34642179\" rel=\"mw:ExtLink nofollow noopener\" target=\"_blank\">34642179<\/a>.<\/cite><\/span><\/li><li data-mw-footnote-number=\"2\">\u00a0<\/li><\/ol><p>\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>FDA DISCLAIMER: These statements have not been evaluated by the Food and Drug Administration (FDA). If you are searching to buy mexidol 125mg USA, please note that Aptechka.store provides 100% original Mexidol 125 mg 30 tablets | Anti Anxiety Relief | Reduces tension &amp; Emotional burnout | Enhances memory | Protects brain cells from oxygen [&hellip;]<\/p>\n","protected":false},"featured_media":9336,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[62],"product_tag":[],"class_list":["post-9335","product","type-product","status-publish","has-post-thumbnail","product_cat-anti-anxiety","first","instock","shipping-taxable","purchasable","product-type-simple"],"_links":{"self":[{"href":"https:\/\/aptechka.store\/es\/wp-json\/wp\/v2\/product\/9335","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aptechka.store\/es\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/aptechka.store\/es\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/aptechka.store\/es\/wp-json\/wp\/v2\/comments?post=9335"}],"version-history":[{"count":15,"href":"https:\/\/aptechka.store\/es\/wp-json\/wp\/v2\/product\/9335\/revisions"}],"predecessor-version":[{"id":9366,"href":"https:\/\/aptechka.store\/es\/wp-json\/wp\/v2\/product\/9335\/revisions\/9366"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aptechka.store\/es\/wp-json\/wp\/v2\/media\/9336"}],"wp:attachment":[{"href":"https:\/\/aptechka.store\/es\/wp-json\/wp\/v2\/media?parent=9335"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/aptechka.store\/es\/wp-json\/wp\/v2\/product_brand?post=9335"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/aptechka.store\/es\/wp-json\/wp\/v2\/product_cat?post=9335"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/aptechka.store\/es\/wp-json\/wp\/v2\/product_tag?post=9335"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}